Related references
Note: Only part of the references are listed.Benznidazole for the treatment of Chagas disease
Irene Losada Galvan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Effects of Mesenchymal Stem Cell-Derived Paracrine Signals and Their Delivery Strategies
Calvin Chang et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
Carolina Kymie Vasques Nonaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
Emanuelle de Souza Santos et al.
FRONTIERS IN IMMUNOLOGY (2020)
Chagas Disease: Epidemiology and Barriers to Treatment
Roger M. Mills
AMERICAN JOURNAL OF MEDICINE (2020)
Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
Felipe Raposo Passos Mansoldo et al.
MOLECULES (2020)
Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization
Cassio Santana Meira et al.
FRONTIERS IN IMMUNOLOGY (2019)
An evaluation of benznidazole as a Chagas disease therapeutic
Ivo S. Caldas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
Manon A. A. Jansen et al.
IMMUNOLOGY (2018)
Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
Angela Maria Lourenco et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study
Cuili Huang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation
Luciana S. Aragao-Franca et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2018)
Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy
Daniela N. Silva et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease
Gonzalo R. Acevedo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy
Fabiola Gonzalez-Herrera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Tolerogenic dendritic cell therapy in organ transplantation
Aurelie Moreau et al.
TRANSPLANT INTERNATIONAL (2017)
Betulinic acid derivative BA5, a dual NF-κB/calcineurin inhibitor, alleviates experimental shock and delayed hypersensitivity
Cassio Santana Meira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
Anis Rassi et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)
Therapeutic effects of sphingosine kinase inhibitor N, N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
Juliana Fraga Vasconcelos et al.
SCIENTIFIC REPORTS (2017)
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease
Agata C. Cevey et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2017)
Tolerance through education: How Tolerogenic Dendritic Cells Shape immunity
Matthias P. Domogalla et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cell therapies for Chagas disease
Adriana Bastos Carvalho et al.
CYTOTHERAPY (2017)
Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Regulatory T Cell and Macrophage Polarization
Eun Ho Choo et al.
CIRCULATION (2017)
Chagas Cardiomyopathy Clinical Presentation and Management in the Americas
Catherine Pastorius Benziger et al.
CARDIOLOGY CLINICS (2017)
Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
Glaucia Vilar-Pereira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cardiac Regeneration using Growth Factors: Advances and Challenges
Juliana de Souza Reboucas et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2016)
Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases
Paulina Garcia-Gonzalez et al.
AUTOIMMUNITY REVIEWS (2016)
Antiparasitic evaluation of betulinic acid derivatives reveals effective and selective anti-Trypanosoma cruzi inhibitors
Cassio Santana Meira et al.
EXPERIMENTAL PARASITOLOGY (2016)
Old and new challenges in Chagas disease
Jose A. Perez-Molina et al.
LANCET INFECTIOUS DISEASES (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8+ T-Cell Response
Isabela Resende Pereira et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity
Debora B. Mello et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Immunity and immune modulation in Trypanosoma cruzi infection
Fabiola Cardillo et al.
PATHOGENS AND DISEASE (2015)
Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis
Jun-Ho Lee et al.
CARDIOVASCULAR RESEARCH (2014)
Chagas Disease Cardiomyopathy: Immunopathology and Genetics
Edecio Cunha-Neto et al.
MEDIATORS OF INFLAMMATION (2014)
Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
Isabela Resende Pereira et al.
MEDIATORS OF INFLAMMATION (2014)
Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed TH1-Type Response
Luciana Gabriel Nogueira et al.
MEDIATORS OF INFLAMMATION (2014)
Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
Isabela Resende Pereira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2014)
Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease
Jasmin et al.
MICROBES AND INFECTION (2014)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cytokine Profiling in Chagas Disease: Towards Understanding the Association with Infecting Trypanosoma cruzi Discrete Typing Units (A BENEFIT TRIAL Sub-Study)
Cristina Poveda et al.
PLOS ONE (2014)
Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
Daniela Nascimento Silva et al.
STEM CELL RESEARCH & THERAPY (2014)
Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy
Ludmila Rodrigues Pinto Ferreira et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
Transplantation of Adipose Tissue Mesenchymal Stem Cells in Experimental Chronic Chagasic Cardiopathy
Ticiana Ferreira Larocca et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2013)
DEXterity of tolerogenic APCs
Katherine E. R. Stagliano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy
Juliana F. Vasconcelos et al.
FASEB JOURNAL (2013)
Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease
Alfredo Molina-Berrios et al.
PARASITOLOGY RESEARCH (2013)
Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
Jose Antonio Marin-Neto et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Cell Therapy in Chagas Cardiomyopathy (Chagas Arm of the Multicenter Randomized Trial of Cell Therapy in Cardiopathies Study) A Multicenter Randomized Trial
Ricardo Ribeiro dos Santos et al.
CIRCULATION (2012)
First century of chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems
Claudio J. Salomon
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Mesenchymal Bone Marrow Cell Therapy in a Mouse Model of Chagas Disease. Where Do the Cells Go?
Jasmin et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Recent developments in sterol 14-demethylase inhibitors for Chagas disease
Frederick S. Buckner et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Bone Marrow Cell Transplantation in Chagas' Disease Heart Failure: Report of The First Human Experience
Fabio Vilas-Boas et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2011)
I Latin American Guidelines for the Diagnosis and Treatment of Chagas' Heart Disease. Executive Summary
Jadelson Pinheiro de Andrade et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2011)
Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells
Milena B. P. Soares et al.
CELL CYCLE (2011)
Pathogenesis of Chagas' Disease: Parasite Persistence and Autoimmunity
Antonio R. L. Teixeira et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Julio A. Urbina
ACTA TROPICA (2010)
Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole
Rodrigo Lopez-Munoz et al.
EXPERIMENTAL PARASITOLOGY (2010)
Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction
Chiharu Enoki et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Gene Expression Changes Associated with Myocarditis and Fibrosis in Hearts of Mice with Chronic Chagasic Cardiomyopathy
Milena Botelho Pereira Soares et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
Yen Ting Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
miR-133 and miR-30 Regulate Connective Tissue Growth Factor Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling
Rudy F. Duisters et al.
CIRCULATION RESEARCH (2009)
Immunological mechanisms of pentoxifylline in chronic heart failure
Steven M. Shaw et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function
Simone G. Macambira et al.
FASEB JOURNAL (2009)
Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy
Edecio Cunha-Neto et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
J. Antonio Marin-Neto et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Perspectives on Trypanosoma cruzi-Induced Heart Disease (Chagas Disease)
Herbert B. Tanowitz et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Current concepts in immunoregulation and pathology of human Chagas disease
Walderez O. Dutra et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance
Fanny Tzelepis et al.
JOURNAL OF IMMUNOLOGY (2008)
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model
Regina C. S. Goldenberg et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges
Paolo Anderlini et al.
BLOOD (2008)
Evaluation and treatment of Chagas disease in the United States - A systematic review
Caryn Bern et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing
Giselle Chamberlain et al.
STEM CELLS (2007)
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evolution and pathology in Chagas disease - A review
Antonio R. L. Teixeira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2006)
Natural regulatory T cells and parasites: a common quest for host homeostasis
Yasmine Belkaid et al.
IMMUNOLOGICAL REVIEWS (2006)
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen
DF Hoft et al.
INFECTION AND IMMUNITY (2005)
Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice
MBP Soares et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a thl-specific immune response
JAS Gomes et al.
INFECTION AND IMMUNITY (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy
K Sliwa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
IL-12 and IFN-γ production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections
MI Antúnez et al.
IMMUNOLOGY LETTERS (2000)
Share Paper
